{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:07:06Z","timestamp":1772773626531,"version":"3.50.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Rush University Cancer Center"},{"name":"Samuel G. Taylor III Chair"}],"content-domain":{"domain":["bloodreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.blre.2014.09.010","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T21:09:55Z","timestamp":1411938595000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies"],"prefix":"10.1016","volume":"29","author":[{"given":"Reem","family":"Karmali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Dalovisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Borgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parameswaran","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly Grant\u2010","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parameswaran","family":"Hari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillard","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2014.09.010_bb0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2013.05.064","article-title":"Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999\u20132010","volume":"62","author":"Beltran-Sanchez","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.blre.2014.09.010_bb0010","series-title":"Harrison's principles of internal medicine","article-title":"The metabolic syndrome","author":"Eckel","year":"2012"},{"key":"10.1016\/j.blre.2014.09.010_bb0015","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.7150\/ijbs.7.1003","article-title":"The link between the metabolic syndrome and cancer","volume":"7","author":"Braun","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.blre.2014.09.010_bb0020","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2014.09.010_bb0025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011\u20132012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2014.09.010_bb0030","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.09.010_bb0035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.med.0000433065.16918.83","article-title":"Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?","volume":"20","author":"Gallagher","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.blre.2014.09.010_bb0040","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/ijc.22762","article-title":"Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0045","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/ijc.23176","article-title":"Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies","volume":"122","author":"Larsson","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0050","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00277-012-1489-z","article-title":"Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can)","volume":"91","author":"Nagel","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2014.09.010_bb0055","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.09.010_bb0060","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/1055-9965.EPI-07-0143","article-title":"Body mass index, physical activity, and risk of multiple myeloma","volume":"16","author":"Birmann","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.blre.2014.09.010_bb0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000354194","article-title":"Impact of interleukin-6 in hematological malignancies","volume":"40","author":"Burger","year":"2013","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.blre.2014.09.010_bb0070","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1182\/blood-2011-01-326025","article-title":"Do reactive oxygen species play a role in myeloid leukemias?","volume":"117","author":"Hole","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb0075","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc3174","article-title":"Molecular mechanisms of cancer development in obesity","volume":"11","author":"Khandekar","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0080","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.bbalip.2013.02.008","article-title":"Mechanisms linking obesity and cancer","volume":"1831","author":"Louie","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.blre.2014.09.010_bb0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10552-010-9697-0","article-title":"Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study","volume":"22","author":"Borena","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2014.09.010_bb0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(82)90543-5","article-title":"Plasma lipid alterations in leukemia and lymphoma","volume":"72","author":"Spiegel","year":"1982","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.blre.2014.09.010_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/bjh.13035","article-title":"SWOG0919: a phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia","volume":"67","author":"Advani","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.010_bb0100","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood-2006-08-044446","article-title":"Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin+high-dose Ara-C: a phase 1 study","volume":"109","author":"Kornblau","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb0105","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/sj.bjc.6605264","article-title":"Serum triglyceride concentrations and cancer risk in a large cohort study in Austria","volume":"101","author":"Ulmer","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0110","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1158\/0008-5472.CAN-07-0212","article-title":"Serum high-density lipoprotein cholesterol and risk of non-Hodgkin lymphoma","volume":"67","author":"Lim","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2014.09.010_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.blre.2014.09.010_bb0120","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1073\/pnas.91.14.6379","article-title":"Fatty acid synthesis: a potential selective target for antineoplastic therapy","volume":"91","author":"Kuhajda","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2014.09.010_bb0125","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2174\/187152011797655122","article-title":"Targeting sphingosine-1-phosphate in hematologic malignancies","volume":"11","author":"Stevenson","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.blre.2014.09.010_bb0130","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/carcin\/18.11.2029","article-title":"Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643","volume":"18","author":"Peters","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.blre.2014.09.010_bb0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/283397a0","article-title":"Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens","volume":"283","author":"Reddy","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.blre.2014.09.010_bb0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clinbiochem.2008.01.027","article-title":"Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients","volume":"41","author":"Battisti","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.blre.2014.09.010_bb0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02982641","article-title":"Oxidative stress and the myelodysplastic syndromes","volume":"77","author":"Farquhar","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.09.010_bb0150","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/leu.2009.49","article-title":"Bcr-Abl-mediated redox regulation of the PI3K\/AKT pathway","volume":"23","author":"Naughton","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.010_bb0155","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1182\/blood-2009-06-222869","article-title":"Ras-induced reactive oxygen species promote growth factor-independent proliferation in human CD34+ hematopoietic progenitor cells","volume":"115","author":"Hole","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb0160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.blre.2014.09.010_bb0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1677\/ERC-10-0083","article-title":"Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells","volume":"17","author":"Bartucci","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0170","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1038\/sj.onc.1206737","article-title":"Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization","volume":"22","author":"Iyengar","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2014.09.010_bb0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fped.2014.00053","article-title":"The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia","volume":"2","author":"Sheng","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.blre.2014.09.010_bb0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.leukres.2012.12.013","article-title":"Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy","volume":"37","author":"Pramanik","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.09.010_bb0185","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1158\/0008-5472.CAN-09-0800","article-title":"Adipocytes impair leukemia treatment in mice","volume":"69","author":"Behan","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2014.09.010_bb0190","doi-asserted-by":"crossref","first-page":"14563","DOI":"10.1074\/jbc.275.19.14563","article-title":"Activation of downstream signals by the long form of the leptin receptor","volume":"275","author":"Banks","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2014.09.010_bb0195","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood.V93.5.1668","article-title":"Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities","volume":"93","author":"Konopleva","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb0200","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2014.09.010_bb0205","first-page":"8","article-title":"Mature response data from a phase 2 study of PI3K-delta inhibitor idelalisib in patients with double (rituximab and alkylating agent)-refractory indolent B-cell non-Hodgkin lymphoma (iNHL)","volume":"12","author":"Gopal","year":"2014","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.010_bb0210","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","article-title":"Idelalisib and rituximab in relapsed chronic lymphocytic leukemia","volume":"370","author":"Furman","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.09.010_bb0215","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc1411","article-title":"Biologically active sphingolipids in cancer pathogenesis and treatment","volume":"4","author":"Ogretmen","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0220","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/hep.23892","article-title":"Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis","volume":"52","author":"Sharma","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.blre.2014.09.010_bb0225","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.bjc.6602896","article-title":"Adiponectin in relation to childhood myeloblastic leukaemia","volume":"94","author":"Petridou","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0230","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ejca.2008.04.015","article-title":"Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system","volume":"44","author":"Dalamaga","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10552-008-9233-7","article-title":"Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case\u2013control study","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2014.09.010_bb0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.blre.2014.09.010_bb0245","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.blre.2014.09.010_bb0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI27280","article-title":"Inflamed fat: what starts the fire?","volume":"116","author":"Neels","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2014.09.010_bb0255","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","article-title":"Obesity and cancer: the role of dysfunctional adipose tissue","volume":"18","author":"van Kruijsdijk","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.blre.2014.09.010_bb0260","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104","article-title":"Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B","volume":"87","author":"Chauhan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb0265","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood.V96.12.3880","article-title":"The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells","volume":"96","author":"Rawstron","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb0270","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1860::AID-CNCR7>3.0.CO;2-R","article-title":"The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma","volume":"82","author":"Stasi","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0275","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.7754\/Clin.Lab.2013.130743","article-title":"Effect of 13q deletion on IL-6 production in patients with multiple myeloma: a hypothesis may hold true","volume":"60","author":"Neemat","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/j.blre.2014.09.010_bb0280","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/ard.2009.117762","article-title":"Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry","volume":"69","author":"Mariette","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2014.09.010_bb0285","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.09.010_bb0290","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2013"},{"key":"10.1016\/j.blre.2014.09.010_bb0295","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1182\/blood-2011-06-362830","article-title":"Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies","volume":"119","author":"Castillo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb0300","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/aje\/kwn160","article-title":"Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis","volume":"168","author":"Chao","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2014.09.010_bb0305","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2337\/dc08-1034","article-title":"Diabetes and risk of non-Hodgkin's lymphoma: a meta-analysis of observational studies","volume":"31","author":"Mitri","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.blre.2014.09.010_bb0310","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/dc12-0002","article-title":"Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults","volume":"35","author":"Campbell","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.blre.2014.09.010_bb0315","series-title":"2014 Pan Pacific Lymphoma Conference","article-title":"Link between metabolic syndrome and survival outcomes in mantle cell lymphoma","author":"Kim","year":"2014"},{"key":"10.1016\/j.blre.2014.09.010_bb0320","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/ijc.22578","article-title":"Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition","volume":"120","author":"Cust","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0325","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ijc.22697","article-title":"Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition","volume":"121","author":"Jenab","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0330","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/ijc.24609","article-title":"Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer","volume":"125","author":"Kabat","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0335","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/cncr.20071","article-title":"Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone\/methotrexate-cytarabine regimen","volume":"100","author":"Weiser","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0340","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.4161\/cc.20770","article-title":"Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells","volume":"11","author":"Pan","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.blre.2014.09.010_bb0345","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/leu.2010.192","article-title":"Insulin is a potent myeloma cell growth factor through insulin\/IGF-1 hybrid receptor activation","volume":"24","author":"Sprynski","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.010_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1758834011427576","article-title":"Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls","volume":"4","author":"Fidler","year":"2012","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.blre.2014.09.010_bb0355","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0327","article-title":"Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms","volume":"220","author":"Guo","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.blre.2014.09.010_bb0360","first-page":"437","article-title":"The IGF axis in the development and progression of prostate cancer","author":"Gregory","year":"2001","journal-title":"Recent Res Dev Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0365","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.blre.2014.09.010_bb0370","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and cellular aspects of the insulin-like growth factor I receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.blre.2014.09.010_bb0375","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1158\/1078-0432.CCR-07-4879","article-title":"The type 1 insulin-like growth factor receptor pathway","volume":"14","author":"Chitnis","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2014.09.010_bb0380","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: the end of the beginning","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.blre.2014.09.010_bb0385","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/1055-9965.EPI-10-0400","article-title":"Serum IGF-I, IGF-II, IGFBP-3, and IGF-I\/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"19","author":"Douglas","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.blre.2014.09.010_bb0390","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1620\/tjem.209.217","article-title":"Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia","volume":"209","author":"Abe","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.blre.2014.09.010_bb0395","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3324\/haematol.2009.010785","article-title":"Autocrine IGF-1\/IGF-1R signaling is responsible for constitutive PI3K\/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody","volume":"95","author":"Chapuis","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.09.010_bb0400","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bmt.1705281","article-title":"Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML","volume":"37","author":"Dawczynski","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.09.010_bb0405","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bmt.1704149","article-title":"Changes of serum growth factors (IGF-I,-II and IGFBP-2,-3) prior to and after stem cell transplantation in children with acute leukemia","volume":"32","author":"Dawczynski","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.09.010_bb0410","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1200\/jco.2014.32.15_suppl.7069","article-title":"Impact of circulating members of the insulin-like growth factor receptor (IGF-1R) axis on outcomes in acute myeloid leukemia","volume":"32","author":"Karmali","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.010_bb0415","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.20110121","article-title":"High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling","volume":"208","author":"Medyouf","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2014.09.010_bb0420","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/leu.2008.57","article-title":"HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia","volume":"22","author":"Whelan","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.010_bb0425","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3324\/haematol.2010.031567","article-title":"Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma","volume":"96","author":"Vishwamitra","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.09.010_bb0430","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3324\/haematol.2012.075184","article-title":"Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma","volume":"98","author":"Barnes","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.09.010_bb0435","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1200\/JCO.2008.20.7977","article-title":"Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma","volume":"27","author":"Hess","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.010_bb0440","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1182\/blood-2008-07-170464","article-title":"The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor","volume":"113","author":"Sprynski","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb0445","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1182\/blood-2011-10-386789","article-title":"Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma","volume":"120","author":"Kuhn","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb9000","unstructured":"www.clinicaltrials.gov."},{"key":"10.1016\/j.blre.2014.09.010_bb0450","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1158\/0008-5472.CAN-07-6721","article-title":"Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver","volume":"68","author":"Jiang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2014.09.010_bb0455","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-08-0022","article-title":"Dietary energy balance modulates signaling through the Akt\/mammalian target of rapamycin pathways in multiple epithelial tissues","volume":"1","author":"Moore","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.blre.2014.09.010_bb0460","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ejh.12285","article-title":"Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"93","author":"Camus","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.09.010_bb0465","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/dc11-1313","article-title":"Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival","volume":"35","author":"Currie","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.blre.2014.09.010_bb0470","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.1825.1825","article-title":"Metformin lowers the mitochondrial potential of lymphoma cells and its use during front-line rituximab-based chemo-immunotherapy improves the clinical outcome of diffuse Large B-cell lymphoma","volume":"122","author":"Singh","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.010_bb0475","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/bjc.2014.307","article-title":"The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma","volume":"111","author":"Wu","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2014.09.010_bb0480","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1038\/cddis.2012.13","article-title":"Therapeutic metformin\/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy","volume":"3","author":"Shi","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.blre.2014.09.010_bb0485","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.2012.06750.x","article-title":"Obesity and cancer risk: evidence, mechanisms, and recommendations","volume":"1271","author":"Vucenik","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2014.09.010_bb0490","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1073\/pnas.1221055110","article-title":"Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth","volume":"110","author":"Hirsch","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2014.09.010_bb0495","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3109\/10428194.2013.862241","article-title":"Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia\/lymphoma","volume":"55","author":"Huang","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.09.010_bb0500","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1158\/0008-5472.CAN-09-0511","article-title":"Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro","volume":"69","author":"Wahner Hendrickson","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2014.09.010_bb0505","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1038\/onc.2009.172","article-title":"Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions","volume":"28","author":"Gualberto","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2014.09.010_bb0510","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/leu.2011.4","article-title":"Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma","volume":"25","author":"Moreau","year":"2011","journal-title":"Leukemia"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T02:55:14Z","timestamp":1598324114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X14000794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0268960X14000794"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2014.09.010","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2014.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}